Literature DB >> 23838742

Elective resection for ongoing diverticular disease significantly improves quality of life.

Bryan J M van de Wall1, Werner A Draaisma, Jan J van Iersel, Esther C J Consten, Marinus J Wiezer, Ivo A M J Broeders.   

Abstract

BACKGROUND: Although the risks of elective resection for diverticular disease are well studied, studies on subjective improvement are scarce. This study aims to investigate subjective improvement.
METHODS: All patients who underwent elective resection for recurring or persisting complaints after an episode of diverticulitis were identified from an in-hospital database. Patients with at least 1 year of follow-up were sent visual analogue scales (VAS) to grade their quality of life (QoL) and the degree of discomfort caused by abdominal pain, abnormal defecation and fatigue before and after resection.
RESULTS: One hundred and five patients responded to the questionnaire (response rate 76.6%). The median follow-up was 33 (15-53) months. Elective resection improved general QoL (median VAS improvement 40) and reduced discomfort caused by abdominal pain (median VAS improvement 60) in up to 89.3 and 87.5% of patients, respectively. The effects of elective resection are less profound for discomfort caused by abnormal defecation (77.1%, median VAS improvement 33) and fatigue (75.2%, median VAS improvement 30).
CONCLUSION: Elective resection of the sigmoid for persisting or recurring symptoms after an episode of diverticulitis improves general QoL and discomfort caused by abdominal pain, abnormal defecation and fatigue in the vast majority of patients.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23838742     DOI: 10.1159/000346482

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  9 in total

Review 1.  Evaluation of Quality of Life and Surgical Outcomes for Treatment of Diverticular Disease.

Authors:  Mayin Lin; Shankar R Raman
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

Review 2.  Elective colonic resection after acute diverticulitis improves quality of life, intestinal symptoms and functional outcome: experts' perspectives and review of literature.

Authors:  Antonello Forgione; Salman Yousuf Guraya
Journal:  Updates Surg       Date:  2016-03-25

Review 3.  Management of sigmoid diverticulitis: an update.

Authors:  Patrick Ambrosetti; Pascal Gervaz
Journal:  Updates Surg       Date:  2016-04-16

4.  Elective vs. early elective surgery in diverticular disease: a retrospective study on the optimal timing of non-emergency treatment.

Authors:  Felix Benjamin Warwas; Berthold Schneider
Journal:  Int J Colorectal Dis       Date:  2018-03-13       Impact factor: 2.571

5.  Long-term bowel dysfunction and decision regret in diverticulitis: A mixed methods study.

Authors:  Noah J Harrison; Molly M Ford; Erin M Wolf Horrell; Michael Feng; Fei Ye; Kevin C Zhang; Alexander T Hawkins
Journal:  Surgery       Date:  2022-08-01       Impact factor: 4.348

6.  Patient Body Image and Satisfaction with Surgical Wound Appearance After Reduced Port Surgery for Colorectal Diseases.

Authors:  Atsushi Hamabe; Ichiro Takemasa; Taishi Hata; Tsunekazu Mizushima; Yuichiro Doki; Masaki Mori
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

Review 7.  The Indications for and Timing of Surgery for Diverticular Disease.

Authors:  Johan Friso Lock; Christian Galata; Christoph Reißfelder; Jörg-Peter Ritz; Thomas Schiedeck; Christoph-Thomas Germer
Journal:  Dtsch Arztebl Int       Date:  2020-08-31       Impact factor: 5.594

8.  Survival after acute colon diverticulitis treated in hospital.

Authors:  Tom-Harald Edna; Aras Jamal Talabani; Stian Lydersen; Birger Henning Endreseth
Journal:  Int J Colorectal Dis       Date:  2014-07-03       Impact factor: 2.571

Review 9.  Health-related quality of life and functional disorders after diverticular surgery.

Authors:  Daniel Segna; Paul J Jaklin; Beat Schnüriger; Benjamin Misselwitz
Journal:  Therap Adv Gastroenterol       Date:  2021-12-23       Impact factor: 4.802

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.